BTMPS: Hindered Amine Light Stabilizer Selection Guide

Bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate (BTMPS) is a benchmark monomeric hindered amine light stabilizer (HALS) widely employed in polymer and materials research to intercept photo-oxidative radical chain reactions and extend the functional lifetime of UV-exposed substrates.

Chemical Name

Bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate

Common Abbreviation

BTMPS

CAS Number

52829-07-9

Functional Class

Monomeric Hindered Amine Light Stabilizer (HALS)

Primary Mechanism

Nitroxyl radical-mediated catalytic scavenging of alkyl and peroxy radicals (Denisov cycle)

Aladdin SKU

B102211

Chemical Identity and Physical Properties

Bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate (BTMPS, CAS 52829-07-9) is a diester formed by esterification of sebacic acid (decanedioic acid) with two equivalents of 2,2,6,6-tetramethyl-4-piperidinol. The compound belongs to the first-generation monomeric HALS family and serves as a reference standard against which newer oligomeric and polymeric HALS are benchmarked.

BTMPS is a white to off-white crystalline solid at room temperature. Its molecular formula is C₂₈H₅₂N₂O₄, with a molecular weight of approximately 480.72 g/mol. The compound exhibits moderate lipophilicity consistent with its long aliphatic backbone, providing reasonable compatibility with non-polar polymer matrices such as polyolefins, polystyrene, and polyurethanes. Solubility in common organic solvents (e.g., chloroform, ethyl acetate, toluene) facilitates solution-processing and incorporation into coatings formulations.

Key physical parameters (verify against current Certificate of Analysis):

• Molecular weight: ~480.72 g/mol
• Melting point: typically reported in the range of 80–85 °C (confirm with current CoA)
• Appearance: white crystalline powder

Mechanism of Action: The HALS Stabilization Cycle

BTMPS functions through a catalytic, regenerative radical-trapping mechanism rather than simple UV absorption. The secondary amine (N–H) moiety of the piperidine ring is oxidized in situ—by hydroperoxides or other oxidants generated during photo-oxidation—to the corresponding nitroxyl radical (≡N–O•). This nitroxyl radical is the primary active species responsible for trapping carbon-centered (alkyl) radicals produced when UV light cleaves C–H bonds in the polymer backbone.

The resulting alkoxyamine (≡N–OR) can subsequently react with peroxy radicals (ROO•) to regenerate the nitroxyl radical, completing the catalytic cycle first described by Denisov and colleagues. Because the nitroxyl radical is continuously regenerated, a single BTMPS molecule can intercept many radical events, providing stabilization efficiency that far exceeds that of stoichiometric antioxidants on a molar basis.

This mechanism is distinct from UV absorbers (e.g., benzophenones, benzotriazoles), which dissipate excitation energy as heat. HALS and UV absorbers are therefore complementary and are frequently co-formulated to achieve broad-spectrum photostabilization.

Selection Criteria and Usage Guidelines

When to choose BTMPS: BTMPS is the preferred reference HALS for laboratory-scale studies requiring a well-characterized, single-component monomeric stabilizer. Its well-documented performance makes it ideal for mechanistic investigations, comparative efficacy studies, and protocol development before scaling to industrial oligomeric HALS.

Recommended loading levels: Typical use concentrations in research formulations range from 0.1–1.0 wt% relative to the polymer matrix, with the optimum determined empirically by accelerated weathering tests (e.g., ASTM G154, ISO 4892-3). Higher loadings may cause surface blooming in some matrices due to the monomeric nature of BTMPS.

Polymer matrix compatibility:

• Well-suited: Polyolefins (PP, PE), polyurethanes, polystyrene, acrylics, coatings
• Use with caution: Acidic polymer systems or formulations containing acidic co-additives may protonate the piperidine nitrogen, reducing HALS activity. Halogen-containing flame retardants can similarly deactivate HALS through acid generation.
• Not recommended: Strongly acidic media or systems where amine functionality is incompatible.

Synergistic combinations: Co-formulate with UV absorbers (benzotriazole or triazine class) for additive or synergistic photostabilization. Combination with hindered phenol antioxidants provides complementary thermal oxidation protection.

Handling, Storage, and Safety Considerations

Storage: Store BTMPS in a tightly sealed container away from light, moisture, and heat at room temperature (15–25 °C) or as specified on the product label and Certificate of Analysis. Proper storage maintains reagent integrity and prevents premature oxidation of the piperidine nitrogen.

Handling precautions: Consult the Safety Data Sheet (SDS) supplied by Aladdin Scientific before use. As a general precaution for fine organic powders: avoid generating and inhaling dust; use appropriate respiratory protection (particulate respirator), nitrile gloves, and safety eyewear when handling bulk quantities. Work in a well-ventilated area or under a fume hood when dissolving in organic solvents.

Incompatibilities: Avoid contact with strong oxidizing agents, strong acids, and strong bases. Acidic conditions can protonate and inactivate the HALS functionality.

Waste disposal: Dispose of waste material in accordance with local, regional, and national regulations. Do not dispose of down the drain without verification of regulatory compliance.

Note: All safety information must be verified against the current Aladdin Scientific SDS for B102211 prior to use.

Experimental Protocol: Incorporation of BTMPS into Polymer Films

The following general protocol outlines incorporation of BTMPS into a polymer matrix for photostability evaluation. Optimize all parameters for your specific system.

1. Determine target loading: Select an initial BTMPS concentration (e.g., 0.5 wt% relative to polymer) based on literature precedents for your polymer class.
2. Solution blending (for solvent-cast films): Dissolve the polymer in a suitable solvent (e.g., chloroform, toluene). Separately dissolve BTMPS in the same solvent at a stock concentration of 10 mg/mL. Combine solutions to achieve the target BTMPS:polymer ratio. Mix thoroughly with gentle stirring or sonication.
3. Film casting: Cast the blended solution onto a clean glass or PTFE substrate using a doctor blade or spin coater. Allow solvent to evaporate slowly at room temperature, then dry under reduced pressure at 40–50 °C for ≥2 h to remove residual solvent.
4. Melt compounding (for thermoplastic systems): Pre-blend BTMPS powder with polymer pellets at the target wt% and process by twin-screw extrusion or melt mixing at a temperature appropriate for the polymer (ensure processing temperature does not exceed BTMPS thermal stability limits; verify with current CoA).
5. Photostability assessment: Expose test specimens to accelerated UV aging (e.g., UV-A 340 nm fluorescent lamps per ASTM G154 or xenon arc per ISO 4892-2). Monitor changes in tensile properties, color (CIE L*a*b*), carbonyl index (FTIR), or molecular weight (GPC) at defined intervals.
6. Controls: Include unstabilized polymer controls and reference formulations with a known HALS for benchmarking.

All protocols should be validated in-house. Consult the relevant ASTM or ISO standards for complete procedural details.

Frequently asked questions

What is the difference between BTMPS and oligomeric or polymeric HALS?

BTMPS is a monomeric HALS with a well-defined molecular structure and molecular weight (~480.72 g/mol), making it ideal for mechanistic research and reproducible laboratory studies. Oligomeric and polymeric HALS have higher molecular weights, which reduce their tendency to migrate or volatilize from polymer matrices during processing or service, generally resulting in better long-term retention in industrial applications. BTMPS is therefore commonly used as a research benchmark rather than a final industrial additive.

Can BTMPS be used in combination with UV absorbers?

Yes. BTMPS and UV absorbers (such as benzotriazoles or triazines) operate by different mechanisms—HALS scavenge radicals while UV absorbers dissipate excitation energy—making them functionally complementary. Co-formulation typically provides additive or synergistic photostabilization, and this approach is standard practice in both research and industrial polymer stabilization. The optimal ratio should be determined empirically for each specific formulation.

Why might BTMPS lose effectiveness in acidic polymer systems?

The photostabilization activity of BTMPS depends on the free electron pair of the piperidine nitrogen. In acidic environments, this nitrogen is protonated, forming an ammonium salt that cannot undergo oxidation to the active nitroxyl radical. As a result, the catalytic radical-trapping cycle is blocked and HALS activity is lost. Acidic co-additives such as certain flame retardants, acid catalysts, or residual process acids should therefore be avoided or their impact assessed when using BTMPS.

What analytical methods are suitable for confirming BTMPS incorporation in a polymer matrix?

Common approaches include HPLC or LC-MS for quantitative determination of BTMPS extracted from the polymer matrix (using appropriate solvents), FTIR spectroscopy for qualitative identification of characteristic amine and ester carbonyl bands, and thermogravimetric analysis (TGA) to assess thermal behavior. Solid-state NMR may also be employed for structural confirmation in research settings.

References

1. Gugumus, F. Mechanisms and kinetics of photostabilization of polyolefins with N-methyl hindered amine light stabilizers. Polym. Degrad. Stab. 1993.
2. Denisov, E.T.; Denisova, T.G. Handbook of Antioxidants: Bond Dissociation Energies, Rate Constants, Activation Energies, and Enthalpies of Reactions, 2nd ed. CRC Press, 2000.
3. Rabek, J.F. Polymer Photodegradation: Mechanisms and Experimental Methods. Chapman & Hall, London, 1995.
4. ASTM G154-16: Standard Practice for Operating Fluorescent Ultraviolet (UV) Lamp Apparatus for Exposure of Nonmetallic Materials.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.